Interazioni tra farmaci
Apalutamide + Pralsetinib
Gravità: Maggiore
Apalutamide and Pralsetinib: major interaction.
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
Sintesi
Apalutamide is a strong CYP3A4 inducer and can substantially lower pralsetinib exposure. This may lead to reduced antitumor efficacy of pralsetinib.
Cosa significa questa interazione in parole semplici
Apalutamide and Pralsetinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Apalutamide belongs to Endocrine; Pralsetinib belongs to Oncology.
Perché avviene
Induction of CYP3A4 (and P-gp) by apalutamide increases the metabolic clearance of pralsetinib.
Cosa fare
Avoid the combination where possible and consider an alternative to apalutamide. If it cannot be avoided, labeling advises doubling the pralsetinib dose from day 7 of the inducer and returning to the original dose after the inducer has been stopped for at least 14 days.
Cosa chiedere al farmacista
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Apalutamide e Pralsetinib, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altre interazioni di Apalutamide
- Apalutamide + Cabotegravir Controindicata
- Apalutamide + Cobicistat Controindicata
- Apalutamide + Doravirine Controindicata
- Apalutamide + Elbasvir / grazoprevir Controindicata
- Apalutamide + Ensitrelvir Controindicata
- Apalutamide + Fostemsavir Controindicata
Altre interazioni di Pralsetinib
- Amobarbital + Pralsetinib Maggiore
- Carbamazepine + Pralsetinib Maggiore
- Chloramphenicol + Pralsetinib Maggiore
- Clarithromycin + Pralsetinib Maggiore
- Efavirenz + Pralsetinib Maggiore
- Enzalutamide + Pralsetinib Maggiore
Domande frequenti
Can I take Apalutamide with Pralsetinib?
MediHelp rates the interaction as major. Apalutamide and Pralsetinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Apalutamide is a strong CYP3A4 inducer and can substantially lower pralsetinib exposure. This may lead to reduced antitumor efficacy of pralsetinib.
How serious is the interaction between Apalutamide and Pralsetinib?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible and consider an alternative to apalutamide. If it cannot be avoided, labeling advises doubling the pralsetinib dose from day 7 of the inducer and returning to the original dose after the inducer has been stopped for at least 14 days.
What other medicines interact with Apalutamide?
MediHelp also lists interactions of Apalutamide with, for example, Cabotegravir, Cobicistat, Doravirine. The full list is on the Apalutamide page.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
